ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,010.60
      0.87%
      US Tech 100
      16,804.40
      0.31%
      Dow Jones
      38,239.98
      0.67%
      Brent Oil
      86.105
      -0.35%
      Bitcoin
      66,306.34
      -0.83%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Akero Therapeutics Inc (AKRO)

      7. Akero Therapeutics Inc (AKRO) News

      AKRO Akero Therapeutics Inc

      20.79
      0.00 (0.00%)
      Pre Market
      Last Updated: 04:00:00
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Akero Therapeutics Inc AKRO NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 20.79 04:00:00
      Open Price Low Price High Price Close Price Prev Close
      20.79
      more quote information »

      Recent News

      Date Time Source Heading
      4/22/20248:49IHNWFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
      3/08/202416:02GLOBEAkero Therapeutics Announces Closing of Public Offering of..
      3/07/202416:01GLOBEAkero Therapeutics Announces Publication of Phase 2b..
      3/06/202420:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202420:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202417:25EDGAR2Form 8-K - Current report
      3/06/202417:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      3/05/202421:13GLOBEAkero Therapeutics Announces Pricing of Public Offering of..
      3/05/202417:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202406:05IHMARKETNEWSAMD Hits Regulatory Roadblock, GitLab’s Stock Tumbles on..
      3/04/202417:34EDGAR2Form 144 - Report of proposed sale of securities
      3/04/202417:30EDGAR2Form 144 - Report of proposed sale of securities
      3/04/202417:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      3/04/202416:21GLOBEAkero Therapeutics Announces Proposed Public Offering of..
      3/04/202407:55EDGAR2Form 8-K - Current report
      3/04/202406:00GLOBEAkero Therapeutics Reports Statistically Significant..
      2/29/202416:42EDGAR2Form S-8 - Securities to be offered to employees in employee..
      2/29/202408:00GLOBEAkero Therapeutics to Present Topline Week 96 Results from..
      2/29/202407:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/29/202407:15EDGAR2Form 8-K - Current report
      2/29/202407:00GLOBEAkero Therapeutics Reports Fourth Quarter and Full Year 2023..
      2/13/202421:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/03/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/03/202408:15GLOBEAkero Therapeutics to Present at the 42nd Annual J.P. Morgan..
      12/29/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/29/202318:07EDGAR2Form 144 - Report of proposed sale of securities
      12/18/202320:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/18/202320:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/18/202320:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/18/202320:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/18/202320:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/18/202307:08EDGAR2Form 8-K - Current report
      12/18/202307:00GLOBEAkero Therapeutics Announces First Patients Dosed in..
      12/12/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/12/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/12/202316:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/12/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/12/202316:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/11/202321:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/11/202320:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/05/202308:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/21/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/13/202317:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/13/202307:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/13/202307:15EDGAR2Form 8-K - Current report
      11/13/202307:00GLOBEAkero Therapeutics Reports Third Quarter 2023 Financial..
      11/10/202308:57GLOBEAkero Therapeutics to Present Late-Breaking Oral and Poster..
      11/08/202307:00GLOBEAkero Therapeutics to Present at Upcoming Healthcare..
      10/17/202316:05GLOBEAkero Therapeutics to Present at the H.C. Wainwright 7th..
      10/10/202308:04EDGAR2Form 8-K - Current report
      10/10/202307:00GLOBEAkero Therapeutics Reports Encouraging 36-Week Analysis of..

      Your Recent History

      NASDAQ
      AKRO
      Akero Therapeutics
      Delayed Upgrade Clock